All posts

Follow Us

LinkedInInstagramX
Quarterly ResultsArchiveLast updated 6 November 20263 min read

Ambar Protein (AMBARPIL) Q2 FY27 Profit Dives 41% as Margins Squeeze

Revenue grew 6.4% year-on-year, but profit before tax halved sequentially as costs rose faster than sales, compressing margins.

By Anant Kacholia, HexaWealth Research · Created 6 November 2026

Ambar Protein's Q2 FY27 shows a sharp contraction in profitability despite higher sales. Net profit fell 41% quarter-on-quarter as operating margins narrowed, highlighting persistent cost pressures in the edible oil sector.

For Ambar Protein, a mid-sized edible oil refiner, the September quarter was a story of top-line resilience meeting a sharp cost squeeze. Revenue climbed to ₹118.8 crore, but profit before tax halved from the previous quarter, landing at ₹2.5 crore.

The numbers reveal the tension. Year-on-year, revenue grew 6.4% and net profit 10%. Sequentially, however, a 4.8% revenue rise was overwhelmed by a 7.4% jump in total expenses, sending net profit down 41%. The net profit margin compressed by 140 basis points to 1.9%.

Revenue & profit

Revenue (₹ Cr)

Profit (₹ Cr)

Net Profit Margin (%)

MetricCurrentQ2 FY27 (Sep 2026)PreviousQ1 FY27 (Jun 2026)
Revenue (₹ Cr)
118.84
113.45
Profit (₹ Cr)
2.20
3.75
Net Profit Margin (%)
1.9
3.3

Why margins collapsed

A key driver was a steep drop in operating profit, which fell 46% quarter-on-quarter according to Flash Finance. This suggests raw material costs, a persistent challenge flagged in the company's FY26 annual report, rose faster than selling prices could adjust. The sector-wide pressure was confirmed by a Grant Thornton Bharat report noting palm oil prices were about 21% higher year-on-year in September.

A working capital trade-off

Cash flow tells another part of the story. Scanx.trade reported a dramatic shift in working capital: inventories fell sharply while trade receivables more than doubled. This indicates the company cleared stock but may have extended credit, tying up cash. Operating cash flow covered only 56% of net profit for the half-year, per Flash Finance.

The outlook hinges on global prices

The near-term path is tied to volatile commodity markets. While Crisil projects healthy 10-12% revenue growth for refiners this fiscal, a government duty cut in September aims to lower consumer prices. This could pressure domestic realisations in the coming quarters. Management, according to StockFin.ai, has provided no explicit guidance, focusing instead on operational efficiency over expansion.

Key Points

  • Net profit fell 41.3% quarter-on-quarter to ₹2.2 crore despite a 4.8% rise in revenue, highlighting severe margin pressure.
  • Operating profit plunged 45.8% sequentially, per Flash Finance, as rising input costs like palm oil outpaced sales.
  • Working capital deteriorated sharply, with receivables doubling and cash balances falling, straining operational cash flow.
  • The company trades at a significant discount to the industry, with a P/E of 11.4 against a sector average of 24.6.

Hexa Perspective

The quarter underscores the fragile economics of a commodity processor in a volatile import-dependent sector. Profitability is hostage to global oil prices and domestic duty changes, with little operating leverage to show. The working capital shift from inventory to receivables may support near-term sales but weakens cash conversion, a critical quality metric. For the stock's deep valuation discount to narrow, investors need evidence of sustained margin discipline or a more favourable commodity cycle—neither of which the Q2 print delivers.

Share or follow HexaWealth

Also read

Want this applied to your portfolio?

Talk to a HexaWealth advisor, or sync your mutual fund data for insights tailored to your holdings.

Ambar Protein Industries (AMBARPIL) Q2 FY27 results, revenue and profits.

Frequently asked questions

What were Ambar Protein Industries' Q2 FY27 results?
Ambar Protein Industries reported Q2 FY27 revenue of ₹118.84 crore, up 6.4% year-on-year. Net profit was ₹2.20 crore, a 10% increase from the year-ago quarter but a sharp 41.3% decline from the previous quarter (Q1 FY27). The net profit margin contracted to 1.9%.
Why did Ambar Protein's Q2 profit drop 41% quarter-on-quarter?
Ambar Protein's Q2 FY27 profit fell 41% sequentially primarily due to a severe margin squeeze. Operating profit plunged 45.8% QoQ, as reported by Flash Finance, indicating that rising raw material costs, including higher palm oil prices, grew much faster than the company's sales revenue during the quarter.
What caused the 140 basis point sequential contraction in net profit margin for Ambar Protein in Q2 FY27?
The 140 basis point QoQ contraction in Ambar Protein's net profit margin to 1.9% was driven by a steep fall in operating profitability. Data from Flash Finance shows the operating profit margin fell 245 basis points to 2.6%, as cost inflation, particularly in edible oil inputs, severely pressured earnings.
Was the profit decline in Ambar Protein Industries' Q2 FY27 driven by higher raw material costs?
Yes, higher raw material costs were a key driver. The company's FY26 annual report cited raw material cost pressures as a primary reason for margin compression. This continued in Q2 FY27, with a Grant Thornton Bharat report noting palm oil prices were about 21% higher year-on-year, squeezing profitability.
What guidance did Ambar Protein management provide for margins and input costs?
Management has not provided explicit forward-looking guidance on margins or costs in recent filings, according to an analysis by StockFin.ai. The stated strategy focuses on improving operating margins through procurement optimization and capacity utilization, rather than outlining specific targets or expectations.
What is the update on Ambar Protein Industries' working capital and cash flow situation in Q2 FY27?
Working capital deteriorated significantly. Scanx.trade reported inventories dropped sharply while trade receivables more than doubled, suggesting slower collections. For the first half of FY27, operating cash flow was only 56% of net profit, indicating weak cash conversion despite reported earnings.
What are Ambar Protein Industries' capex plans and new technological advancements?
The company's strategy, as noted by StockFin.ai, is currently focused on consolidation and margin recovery through operational efficiency. There are no disclosed plans for major new capex, business diversification, or technological expansions; the emphasis remains on optimizing existing operations and prudent capital allocation.
Did Ambar Protein Industries' Q2 FY27 results beat or miss analyst estimates?
There is no available data on consensus analyst estimates for Ambar Protein's Q2 FY27 results. An analysis by Flash Finance noted the company's profit was 27% above its own historical trend, but this is not a comparison to published analyst forecasts.
How did Ambar Protein Industries' stock price react on the day of the Q2 FY27 results announcement?
Specific intraday reaction data for November 14, 2026, is not available in the provided research. Broader data shows the stock was trading around ₹189 in early November, having declined nearly 30% over the preceding year, reflecting weak investor sentiment.
Are there any regulatory changes affecting the Indian edible oil industry that impacted Ambar Protein?
Yes. In September 2026, the government cut import duties on major crude edible oils to moderate domestic prices, as reported by the Press Information Bureau. This duty rationalisation is expected to lower industry realisations in the second half of the fiscal year, potentially pressuring refiners' margins.
Did promoter or institutional holdings in Ambar Protein Industries change significantly in the September 2026 quarter?
Promoter holding increased slightly to 73.87% as of September 2026, up from 73.76% in June 2026, per Stockexact.com data. There is no significant institutional holding reported, with FII and DII ownership remaining at 0%.
Ambar Protein Industries Q2 profit drop
Ambar Protein Industries' Q2 FY27 net profit dropped 41.3% quarter-on-quarter to ₹2.20 crore. This decline occurred despite a 4.8% rise in revenue, as operating margins were squeezed by a sharp increase in input costs, particularly for edible oils like palm oil.
Ambar Protein Industries Q2 FY27 results
Ambar Protein Industries announced its Q2 FY27 results on November 14, 2026. The company reported revenue of ₹118.84 crore and a net profit of ₹2.20 crore for the quarter ended September 2026. Year-on-year profit grew 10%, but it fell sharply from the previous quarter's ₹3.75 crore.